Association of gut-related metabolites with outcome in acute heart failure
Association of gut-related metabolites with outcome in acute heart failure
复制标题
DOI:
10.1016/j.ahj.2021.01.006
复制
发表时间:
2021-01-26
影响因子:
4.8
通讯作者:
Suzuki, Toru
中科院分区:
文献类型:
--
作者:
Israr, Muhammad Zubair;Bernieh, Dennis;Suzuki, Toru
Background Trimethylamine N-oxide (TMAO), a gut-related metabolite, is associated with heart failure (HF) outcomes. However, TMAO is the final product of a complex metabolic pathway (ie, choline/carnitine) that has never been entirely investigated in HF. The present study investigates a panel of metabolites involved in the TMAO-choline/carnitine metabolic pathway for their associations with outcome in acute HF patients.Methods In total, 806 plasma samples from acute HF patients were analyzed for TMAO, trimethyllysine, L-carnitine, acetyl-L-carnitine, gamma-butyrobetaine, crotonobetaine, trimethylamine, betaine aldehyde, choline, and betaine using a developed liquid chromatography-tandem mass spectrometry method. Associations with outcome of all-cause mortality (death) and a composite of all-cause mortality and/or rehospitalization caused by HF (death/HF) at 30 days and 1 year were investigated.Results TMAO, trimethyllysine, L-carnitine, acetyl-L-carnitine, and gamma-butyrobetaine were associated with death and death/HF at 30 days (short term; hazard ratio 1.30-1.49, P